FTSE closes lower as near-term global growth outlook darkens

The FTSE is heading into the close just shy of 1% lower as fears over the near-term economic growth outlook overshadowed more upbeat vaccine news.

Downtrend 5

FTSE closes lower as near-term global growth outlook darkens

The FTSE is heading into the close just shy of 1% lower as fears over the near-term economic growth outlook overshadowed more upbeat vaccine news.  

This time it was the turn of AstraZeneca to inform as to how its covid -19 vaccine is performing in recent trials. The vaccine was found to provoke a robust immune response, particularly in older adults in Phase 2 trials. Whilst this is great news, after the big hitting data from Pfizer and Moderna this week, AstraZeneca’s was insufficient to overshadow fears of rising covid cases, tighter lockdowns and the impact on the economy. 

The IMF confirmed the market’s fears warning that whilst the global economy is recovering from the depths of the covid crisis, there are signs that the recovery is running out of steam, particularly in countries were cases are on the rise. 

As if on cue US initial jobless claims unexpectedly rose last week to 742k, up from 711k previously and well above the 707k expected. The rise in claims reflects the impact the resurgence of covid, tightening lockdown restrictions and the absence of additional fiscal stimulus from is having on the labour market recovery. 

Source: TradingView, GAIN Capital

Royal Mail takes a step on IPO price 

There have been some bright spots early on in the session with Royal Mail finding itself an unexpected winner of the covid pandemic. Royal Mail reported an impressive 9.8% increase in first half revenue as letter volumes drop but parcels more than compensated. With parcels now making up for 60% of revenue, the postal deliveries group has crossed an important threshold whereby parcel deliveries have surpassed letters thanks to a surge in online shopping. This bodes well for the future given that online shopping isn’t expected to drop off even with a vaccine.  Even so that wasn’t enough to prevent a serious hit to profits, which fell 90.2% to £17 million. rise in costs #RM slumped into an operating loss of £20m. 

The stock closed 3% higher just shy of 300p a level last seen almost 2 years earlier. 

Dollar rises, Pound slips on Brexit jitters 

In the FX space, the Dollar dominated, boosted by risk flows as investors sought out its safe haven properties. The Pound fell against both the USD and EUR as Brexit jitters got the better of investors as the EU Summit kicks off and bulls are preferring to wait on the side-lines ahead of any market moving headlines. 

Build your confidence risk free

More from FTSE 100

Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.